Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Erlotinib | 19.9526 | uM | 10 | 5000.00 | 2314.91 | 5495.00 | 6615.25 | 0.8307 | 0.7695 |
MDA-MB-231 | 17-AAG | 0.0016596 | uM | 10 | 5000.00 | 2314.91 | 6782.00 | 6615.25 | 1.0252 | 1.0331 |
MDA-MB-231 | 17-AAG | 10 | uM | 10 | 5000.00 | 2314.91 | 2682.00 | 6615.25 | 0.4054 | 0.1020 |
MDA-MB-231 | Linsitinib | 0.01 | uM | 10 | 5000.00 | 2314.91 | 6645.00 | 6615.25 | 1.0045 | 1.0059 |
MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6751.00 | 6615.25 | 1.0205 | 1.0270 | |
MDA-MB-231 | Linsitinib | 10 | uM | 10 | 5000.00 | 2314.91 | 5279.00 | 6615.25 | 0.7980 | 0.7232 |
MDA-MB-231 | Linsitinib | 19.9526 | uM | 10 | 5000.00 | 2314.91 | 4457.00 | 6615.25 | 0.6738 | 0.5410 |
MDA-MB-231 | Erlotinib | 0.31623 | uM | 10 | 5000.00 | 2314.91 | 6623.00 | 6615.25 | 1.0012 | 1.0015 |
MDA-MB-231 | 17-AAG | 0.0033113 | uM | 10 | 5000.00 | 2314.91 | 6771.00 | 6615.25 | 1.0235 | 1.0310 |
MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6660.00 | 6615.25 | 1.0068 | 1.0089 | |
MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6516.00 | 6615.25 | 0.9850 | 0.9801 | |
MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6219.00 | 6615.25 | 0.9401 | 0.9201 | |
MDA-MB-231 | 17-AAG | 0.01 | uM | 10 | 5000.00 | 2314.91 | 6174.00 | 6615.25 | 0.9333 | 0.9109 |
MDA-MB-231 | 17-AAG | 0.31623 | uM | 10 | 5000.00 | 2314.91 | 6024.00 | 6615.25 | 0.9106 | 0.8801 |
MDA-MB-231 | 17-AAG | 0.1 | uM | 10 | 5000.00 | 2314.91 | 6295.00 | 6615.25 | 0.9516 | 0.9356 |
MDA-MB-231 | Erlotinib | 0.031623 | uM | 10 | 5000.00 | 2314.91 | 6541.00 | 6615.25 | 0.9888 | 0.9852 |
MDA-MB-231 | Erlotinib | 1 | uM | 10 | 5000.00 | 2314.91 | 6876.00 | 6615.25 | 1.0394 | 1.0517 |
MDA-MB-231 | Linsitinib | 0.31623 | uM | 10 | 5000.00 | 2314.91 | 6457.00 | 6615.25 | 0.9761 | 0.9683 |
MDA-MB-231 | Lapatinib | 3.1623 | uM | 10 | 5000.00 | 2314.91 | 6310.00 | 6615.25 | 0.9539 | 0.9386 |
MDA-MB-231 | 17-AAG | 0.031623 | uM | 10 | 5000.00 | 2314.91 | 6663.00 | 6615.25 | 1.0072 | 1.0095 |
MDA-MB-231 | Erlotinib | 0.1 | uM | 10 | 5000.00 | 2314.91 | 6817.00 | 6615.25 | 1.0305 | 1.0401 |
MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6704.00 | 6615.25 | 1.0134 | 1.0177 | |
MDA-MB-231 | Linsitinib | 0.1 | uM | 10 | 5000.00 | 2314.91 | 6786.00 | 6615.25 | 1.0258 | 1.0339 |
MDA-MB-231 | Lapatinib | 0.0016596 | uM | 10 | 5000.00 | 2314.91 | 6801.00 | 6615.25 | 1.0281 | 1.0369 |
MDA-MB-231 | Lapatinib | 0.0033113 | uM | 10 | 5000.00 | 2314.91 | 6749.00 | 6615.25 | 1.0202 | 1.0266 |